MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cardiovascular, Cardiac & Cardiology Companies _ Congestive Heart Failure (CHF)
CardioStory
Attachments
Home
Parents
Architects: Cardiovascular, Cardiac & Cardiology Companies
Architects: Cardiovascular, Cardiac & Cardiology Companies _ Congestive Heart Failure (CHF)
FDA _ Breakthrough Devices Program
Industry: Delaware
Children
2022: CardioStory’s Cardiac Monitor Designated an FDA Breakthrough Device
CardioStory combines patented, proprietary sensor technology with advanced algorithms to build a Non-Invasive Filling Pressure (NIFP) measurement and monitoring platform for heart failure patients.
CardioStory is building a Non-Invasive Filling Pressure (NIFP) measurement and monitoring platform for heart failure patients.
Lewes, Delaware
The company is dedicated to building a digital health platform to address the full spectrum of care to cardiovascular diseases and respiratory diseases, including but not limited to heart failure, atrial fibrillation, coronary artery disease, COPD, asthma and etc.